Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]

Linxuan Wu,1,* Jian Hu,2,3,* Peng Yao2,3 1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;...

Full description

Saved in:
Bibliographic Details
Main Authors: Wu L, Hu J, Yao P
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:Drug Design, Development and Therapy
Online Access:https://www.dovepress.com/potential-cardiovascular-risks-associated-with-naltrexone-bupropion-tr-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846136646049726464
author Wu L
Hu J
Yao P
author_facet Wu L
Hu J
Yao P
author_sort Wu L
collection DOAJ
description Linxuan Wu,1,* Jian Hu,2,3,* Peng Yao2,3 1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 3National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China*These authors contributed equally to this workCorrespondence: Peng Yao, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 150006, People’s Republic of China, Email 75232745@qq.com
format Article
id doaj-art-e3af0a79af9243209fab31ffc654436d
institution Kabale University
issn 1177-8881
language English
publishDate 2024-12-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj-art-e3af0a79af9243209fab31ffc654436d2024-12-08T17:58:38ZengDove Medical PressDrug Design, Development and Therapy1177-88812024-12-01Volume 185793579498098Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]Wu LHu JYao PLinxuan Wu,1,* Jian Hu,2,3,* Peng Yao2,3 1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 3National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China*These authors contributed equally to this workCorrespondence: Peng Yao, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 150006, People’s Republic of China, Email 75232745@qq.comhttps://www.dovepress.com/potential-cardiovascular-risks-associated-with-naltrexone-bupropion-tr-peer-reviewed-fulltext-article-DDDT
spellingShingle Wu L
Hu J
Yao P
Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]
Drug Design, Development and Therapy
title Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]
title_full Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]
title_fullStr Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]
title_full_unstemmed Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]
title_short Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Letter]
title_sort potential cardiovascular risks associated with naltrexone bupropion treatment in overweight patients letter
url https://www.dovepress.com/potential-cardiovascular-risks-associated-with-naltrexone-bupropion-tr-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT wul potentialcardiovascularrisksassociatedwithnaltrexonebupropiontreatmentinoverweightpatientsletter
AT huj potentialcardiovascularrisksassociatedwithnaltrexonebupropiontreatmentinoverweightpatientsletter
AT yaop potentialcardiovascularrisksassociatedwithnaltrexonebupropiontreatmentinoverweightpatientsletter